Carl Dambkowski - Aug 29, 2024 Form 3 Insider Report for Oruka Therapeutics, Inc. (ORKA)

Role
Director
Signature
/s/ Paul Quinlan, as attorney-in-fact for Carl Dambkowski
Stock symbol
ORKA
Transactions as of
Aug 29, 2024
Transactions value $
$0
Form type
3
Date filed
9/6/2024, 05:05 PM
Previous filing
Aug 9, 2024
Next filing
Sep 6, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ORKA Stock Option (Right to Buy) Aug 29, 2024 Common Stock 71.4K $6.84 Direct F1
holding ORKA Warrant (Right to Buy) Aug 29, 2024 Common Stock 22.9K $7.80 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase 71,426 shares of the Issuer's common stock, one quarter of which will vest on March 1, 2025, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
F2 This warrant represents a right to purchase 22,856 shares of the Issuer's common stock, one quarter of which will vest on April 3, 2025, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney